• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠/钙交换抑制通过阻断能量消耗过程保护大鼠心脏免受缺血-再灌注损伤。

Na+/Ca2+ exchange inhibition protects the rat heart from ischemia-reperfusion injury by blocking energy-wasting processes.

作者信息

Hagihara Hiroji, Yoshikawa Yoshiro, Ohga Yoshimi, Takenaka Chikako, Murata Ken-ya, Taniguchi Shigeki, Takaki Miyako

机构信息

Dept. of Physiology II, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

出版信息

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1699-707. doi: 10.1152/ajpheart.01033.2004. Epub 2004 Dec 30.

DOI:10.1152/ajpheart.01033.2004
PMID:15626686
Abstract

We have recently reported that exposure of rat hearts to high Ca(2+) produces a Ca(2+) overload-induced contractile failure in rat hearts, which was associated with proteolysis of alpha-fodrin. We hypothesized that contractile failure after ischemia-reperfusion (I/R) is similar to that after high Ca(2+) infusion. To test this hypothesis, we investigated left ventricular (LV) mechanical work and energetics in the cross-circulated rat hearts, which were subjected to 15 min global ischemia and 60 min reperfusion. Sixty minutes after I/R, mean systolic pressure-volume area (PVA; a total mechanical energy per beat) at midrange LV volume (mLVV) (PVA(mLVV)) was significantly decreased from 5.89 +/- 1.55 to 3.83 +/- 1.16 mmHg.ml.beat(-1).g(-1) (n = 6). Mean myocardial oxygen consumption per beat (Vo(2)) intercept of (Vo(2)-PVA linear relation was significantly decreased from 0.21 +/- 0.05 to 0.15 +/- 0.03 microl O(2).beat(-1).g(-1) without change in its slope. Initial 30-min reperfusion with a Na(+)/Ca(2+) exchanger (NCX) inhibitor KB-R7943 (KBR; 10 micromol/l) significantly reduced the decrease in mean PVA(mLVV) and Vo(2) intercept (n = 6). Although Vo(2) for the Ca(2+) handling was finally decreased, it transiently but significantly increased from the control for 10-15 min after I/R. This increase in Vo(2) for the Ca(2+) handling was completely blocked by KBR, suggesting an inhibition of reverse-mode NCX by KBR. alpha-Fodrin proteolysis, which was significantly increased after I/R, was also significantly reduced by KBR. Our study shows that the contractile failure after I/R is similar to that after high Ca(2+) infusion, although the contribution of reverse-mode NCX to the contractile failure is different. An inhibition of reverse-mode NCX during initial reperfusion protects the heart against reperfusion injury.

摘要

我们最近报道,将大鼠心脏暴露于高钙(Ca2+)环境会导致大鼠心脏出现钙超载诱导的收缩功能衰竭,这与α-血影蛋白的蛋白水解有关。我们推测,缺血再灌注(I/R)后的收缩功能衰竭与高钙灌注后的情况相似。为了验证这一假设,我们研究了交叉循环大鼠心脏的左心室(LV)机械功和能量代谢,这些心脏经历了15分钟的全心缺血和60分钟的再灌注。I/R后60分钟,左心室中等容积(mLVV)时的平均收缩压-容积面积(PVA;每搏总机械能)(PVA(mLVV))从5.89±1.55显著降至3.83±1.16 mmHg·ml·beat-1·g-1(n = 6)。每搏平均心肌耗氧量(Vo2)与(Vo2 - PVA线性关系的截距从0.21±0.05显著降至0.15±0.03 μl O2·beat-1·g-1,斜率无变化。用钠/钙交换体(NCX)抑制剂KB-R7943(KBR;10 μmol/l)进行最初30分钟的再灌注,显著减少了平均PVA(mLVV)和Vo2截距的下降(n = 6)。尽管最终钙处理的Vo2下降,但I/R后10 - 15分钟内它短暂但显著高于对照组。KBR完全阻断了钙处理的Vo2的这种增加,表明KBR抑制了反向模式的NCX。I/R后显著增加的α-血影蛋白蛋白水解也被KBR显著减少。我们的研究表明,I/R后的收缩功能衰竭与高钙灌注后的情况相似,尽管反向模式NCX对收缩功能衰竭的作用不同。在最初再灌注期间抑制反向模式NCX可保护心脏免受再灌注损伤。

相似文献

1
Na+/Ca2+ exchange inhibition protects the rat heart from ischemia-reperfusion injury by blocking energy-wasting processes.钠/钙交换抑制通过阻断能量消耗过程保护大鼠心脏免受缺血-再灌注损伤。
Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1699-707. doi: 10.1152/ajpheart.01033.2004. Epub 2004 Dec 30.
2
Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics.钙蛋白酶抑制剂-1保护大鼠心脏免受缺血-再灌注损伤:通过机械功和能量学分析
Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1690-8. doi: 10.1152/ajpheart.00666.2004. Epub 2004 Nov 4.
3
Inhibition by KB-r7943 of the reverse mode of the Na+/Ca2+ exchanger reduces Ca2+ overload in ischemic-reperfused rat hearts.KB-r7943对钠/钙交换体逆向模式的抑制作用可减轻缺血再灌注大鼠心脏的钙超载。
Circ J. 2002 Apr;66(4):390-6. doi: 10.1253/circj.66.390.
4
Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.线粒体功能的维持可能有助于钠/钙交换体抑制剂对缺血/再灌注大鼠心脏的心脏保护作用。
Br J Pharmacol. 2007 Aug;151(7):963-78. doi: 10.1038/sj.bjp.0707321. Epub 2007 Jun 4.
5
A new calpain inhibitor protects left ventricular dysfunction induced by mild ischemia-reperfusion in in situ rat hearts.一种新型钙蛋白酶抑制剂对在体大鼠轻度缺血再灌注诱导的左心室功能障碍的保护作用。
J Physiol Sci. 2013 Mar;63(2):113-23. doi: 10.1007/s12576-012-0243-6. Epub 2012 Dec 16.
6
Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest.新型钙蛋白酶抑制剂 SNJ-1945 对心脏停搏后再灌注损伤的心脏保护作用。
Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H643-51. doi: 10.1152/ajpheart.00849.2009. Epub 2009 Dec 4.
7
Very low dose of the Na(+)/Ca(2+) exchange inhibitor, KB-R7943, protects ischemic reperfused aged Fischer 344 rat hearts: considerable strain difference in the sensitivity to KB-R7943.极低剂量的Na(+)/Ca(2+)交换抑制剂KB-R7943可保护缺血再灌注的老年Fischer 344大鼠心脏:对KB-R7943的敏感性存在显著品系差异。
Cardiovasc Res. 2001 Dec;52(3):397-406. doi: 10.1016/s0008-6363(01)00409-6.
8
Participation of Na/Ca-exchanger and sarcoplasmic reticulum in the high [K]-protection against ischaemia-reperfusion dysfunction in rat hearts.钠/钙交换体和肌浆网在大鼠心脏高钾保护缺血再灌注功能障碍中的作用。
Acta Physiol Scand. 2004 Oct;182(2):121-32. doi: 10.1111/j.1365-201X.2004.01342.x.
9
Detrimental effects after dobutamine infusion on rat left ventricular function: mechanical work and energetics.多巴酚丁胺输注后对大鼠左心室功能的有害影响:机械功和能量学
Exp Physiol. 2005 Jul;90(4):635-44. doi: 10.1113/expphysiol.2005.030460. Epub 2005 Apr 22.
10
Left ventricular mechanoenergetics after hyperpolarized cardioplegic arrest by nicorandil and after depolarized cardioplegic arrest by KCl.尼可地尔超极化心脏停搏和氯化钾去极化心脏停搏后的左心室机械能量学
Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1072-80. doi: 10.1152/ajpheart.00133.2004. Epub 2004 Apr 22.

引用本文的文献

1
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis.药物调节线粒体钙单向转运体控制囊性纤维化中的肺部炎症。
Sci Adv. 2020 May 6;6(19):eaax9093. doi: 10.1126/sciadv.aax9093. eCollection 2020 May.
2
Cardiac sodium/calcium exchanger preconditioning promotes anti-arrhythmic and cardioprotective effects through mitochondrial calcium-activated potassium channel.心脏钠/钙交换体预处理通过线粒体钙激活钾通道促进抗心律失常和心脏保护作用。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10239-49. eCollection 2015.
3
KB-R7943, a plasma membrane Na(+)/Ca(2+) exchanger inhibitor, blocks opening of the mitochondrial permeability transition pore.
KB-R7943,一种质膜 Na(+)/Ca(2+) 交换体抑制剂,可阻断线粒体通透性转换孔的开放。
Biochem Biophys Res Commun. 2014 Jan 31;444(1):44-9. doi: 10.1016/j.bbrc.2014.01.009. Epub 2014 Jan 14.
4
Regulation of the Na+/Ca2+ exchanger by pyridine nucleotide redox potential in ventricular myocytes.心肌细胞中吡啶核苷酸氧化还原电势对 Na+/Ca2+ 交换体的调节作用。
J Biol Chem. 2013 Nov 1;288(44):31984-92. doi: 10.1074/jbc.M113.496588. Epub 2013 Sep 17.
5
A new calpain inhibitor protects left ventricular dysfunction induced by mild ischemia-reperfusion in in situ rat hearts.一种新型钙蛋白酶抑制剂对在体大鼠轻度缺血再灌注诱导的左心室功能障碍的保护作用。
J Physiol Sci. 2013 Mar;63(2):113-23. doi: 10.1007/s12576-012-0243-6. Epub 2012 Dec 16.
6
Increased O2 consumption in excitation-contraction coupling in hypertrophied rat heart slices related to increased Na+ -Ca2+ exchange activity.肥大大鼠心脏切片中兴奋 - 收缩偶联过程中氧消耗增加与钠 - 钙交换活性增强有关。
J Physiol Sci. 2009 Jan;59(1):63-74. doi: 10.1007/s12576-008-0006-6. Epub 2008 Dec 11.
7
Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.线粒体功能的维持可能有助于钠/钙交换体抑制剂对缺血/再灌注大鼠心脏的心脏保护作用。
Br J Pharmacol. 2007 Aug;151(7):963-78. doi: 10.1038/sj.bjp.0707321. Epub 2007 Jun 4.
8
The plasma membrane Na+/Ca2+ exchange inhibitor KB-R7943 is also a potent inhibitor of the mitochondrial Ca2+ uniporter.质膜钠/钙交换抑制剂KB-R7943也是线粒体钙单向转运体的有效抑制剂。
Br J Pharmacol. 2007 Jul;151(5):647-54. doi: 10.1038/sj.bjp.0707260. Epub 2007 Apr 30.